City Pedia Web Search

Search results

1. Results From The WOW.Com Content Network

2. Therapeutic Approaches in Facioscapulohumeral Muscular Dystrophy

   www.ncbi.nlm.nih.gov/pmc/articles/PMC8048701

   Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common types of muscular dystrophy affecting roughly 1 in 8,000 individuals. The complex underlying genetics and poor mechanistic understanding has caused a bottleneck in therapeutic development.

3. Facioscapulohumeral Muscular Dystrophy - StatPearls - NCBI...

   www.ncbi.nlm.nih.gov/books/NBK559028

   This activity outlines the evaluation and treatment of facioscapulohumeral muscular dystrophy and explains the role of the interprofessional team in improving the care of patients with this condition.

4. Facioscapulohumeral muscular dystrophy - UpToDate

   www.uptodate.com/contents/facioscapulohumeral-muscular-dystrophy

   It is a complex genetic disorder characterized in most cases by slowly progressive muscle weakness involving the facial, scapular, upper arm, lower leg, and hip girdle muscles, usually with asymmetric involvement. The clinical aspects of facioscapulohumeral muscular dystrophies are discussed here.

5. Facioscapulohumeral Muscular Dystrophy: Treatment and More

   www.verywellhealth.com/facioscapulohumeral-muscular-dystrophy-overview-5210065

   Treatment. Prognosis. Coping. Frequently Asked Questions. Facioscapulohumeral muscular dystrophy (FSHD) is the third most common type of muscular dystrophy. Although it also causes progressive muscle weakness, FSHD does not shorten your life expectancy as other forms of muscular dystrophy do.

6. FSHD (Facioscapulohumeral Muscular Dystrophy) - Cleveland Clinic

   my.clevelandclinic.org/health/diseases/facioscapulohumeral-muscular-dystrophy-fshd

   Facioscapulohumeral muscular dystrophy (FSHD) is an inherited disease that often affects muscles in your face and upper body but can spread to any muscle in your body. Symptoms typically develop between adolescence and age 20 to 30. There’s no cure for FSHD, but there are therapies to ease your symptoms and help you keep up your quality of life.

7. Current Therapeutic Approaches in FSHD - PMC - National Center...

   www.ncbi.nlm.nih.gov/pmc/articles/PMC8203219

   Facioscapulohumeral dystrophy (FSHD) is the third most common muscular dystrophy after Duchenne muscular dystrophy and myotonic dystrophy, with a prevalence of ∼12–15 per 100,000 [1, 2]. Age of onset is variable with presentations at birth to late in life.

8. Facioscapulohumeral Muscular Dystrophy (FSH, FSHD)

   www.mda.org/disease/facioscapulohumeral-muscular-dystrophy

   Facioscapulohumeral muscular dystrophy (FSHD) is a genetic muscle disorder in which the muscles of the face, shoulder blades, and upper arms are among the most affected.

9. Updates on Facioscapulohumeral Muscular Dystrophy (FSHD)

   link.springer.com/article/10.1007/s11940-024-00790-x

   Summary. Given the absence of approved disease-modifying treatments for FSHD, the primary approach for management currently involves multidisciplinary supportive measures which are limited. Recent developments in the form of targeted therapies and strategies for the definitive treatment of FSHD indicate a promising era.

10. Facioscapulohumeral Muscular Dystrophy (FSH, FSHD)

    www.mda.org/disease/facioscapulohumeral-muscular-dystrophy/medical-management

    Medical treatments for facioscapulohumeral muscular dystrophy (FSHD) are relatively few, and none are specific to the disease. There is no treatment that can halt or reverse the effects of FSHD, but there are treatments and devices to help alleviate many of the symptoms.

11. Facioscapulohumeral Muscular Dystrophy Info - Treatment - FSHD...

    www.fshdsociety.org

    Ensuring no one faces Facioscapulohumeral Muscular Dystrophy (FSHD) alone. Our goal for all impacted by FSHD is two-fold: 1) Speed the delivery of effective treatments and a cure and; 2) Ensure those impacted have what they need to live their best life.